FrancophonIA/ELRC3.0 huggingface dataset:
English: The Lopinavir/Ritonavir Mylan tablets dosage should be increased to 500/125 mg twice daily when coadministered with nevirapine.
Slovenian: Med sočasno uporabo z nevirapinom je treba odmerek tablet zdravila Lopinavir/ritonavir Mylan povečati na 500 mg/125 mg dvakrat na dan.
English: - Multipacks containing 60 or 60x1 (2 cartons of 30 or 30x1) film-coated tablets.
Slovenian: Na voljo so naslednje velikost pakiranj: - Skupno pakiranje s 60 ali 60 x 1 (2 škatli po 30 ali 30 x 1) filmsko obloženo tableto.
English: Concomitant use of sildenafil prescribed for the treatment of pulmonary arterial hypertension with lopinavir/ritonavir is contraindicated (see section 4.3).
Slovenian: Sočasna uporaba sildenafila za zdravljenje pljučne arterijske hipertenzije in lopinavirja/ritonavirja je kontraindicirana (glejte poglavje 4.3).
English: Bedaquiline: AUC: ↑ 22% Cmax: ↔
Slovenian: AUC: ↑ 22% Cmax: ↔
English: If the use of atorvastatin is considered strictly necessary, the lowest possible dose of atorvastatin should be administered with careful safety monitoring.
Slovenian: Če je zdravljenje z atorvastatinom nujno, je treba uporabiti najmanjši možni odmerek atorvastatina in natančno spremljati varnost.Previdnost je potrebna tudi pri hkratni uporabi lopinavirja/ritonavirja z rosuvastatinom; razmisliti je treba o zmanjšanju odmerkov.
English: You must not take Lopinavir/Ritonavir Mylan with colchicine if you have kidney and/or liver problems (see also ‘Do not take Lopinavir/Ritonavir Mylan' above);
Slovenian: Zdravila Lopinavir/ritonavir Mylan ne smete jemati skupaj s kolhicinom, če imate težave z ledvicami in/ali jetri (glejte tudi ''Ne jemljite zdravila Lopinavir/ritonavir Mylan'' zgoraj); - zdravila za zdravljenje tuberkuloze (bedakilin, delamanid); - protivirusna zdravila za zdravljenje kronične okužbe z virusom hepatitisa C (HCV) pri odraslih
English: Lopinavir/Ritonavir Mylan 100 mg/25 mg film-coated tablets Approx 15.0 mm x 8.0 mm, white, film coated, ovaloid, biconvex beveled edge tablet debossed with 'MLR4' on one side of the tablet and plain on the other side.
Slovenian: Zdravilo Lopinavir/ritonavir Mylan 100 mg/25 mg filmsko obložene tablete Bela, približno ovalna, bikonvensna filmsko obložena tableta z zglajenim robom, dimenzij približno 15,0 mm x 8,0 mm, z vtisnjeno oznako "MLR4" na eni strani in brez oznake na drugi strani.
English: What Lopinavir/Ritonavir Mylan looks like and contents of the pack
Slovenian: Izgled zdravila Lopinavir/ritonavir Mylan in vsebina pakiranja
English: Osteonecrosis
Slovenian: Hemofilija
English: Co-administration of increased doses of fosamprenavir (1400 mg BID) with lopinavir/ritonavir (533/133 mg BID) to protease inhibitor-experienced patients resulted in a higher incidence of gastrointestinal adverse events and elevations in triglycerides with the combination regimen without increases in virological efficacy, when compared with standard doses of fosamprenavir/ritonavir.
Slovenian: Bolnikom, ki so že dobivali zaviralce proteaz, je sočasna uporaba večjih odmerkov fosamprenavirja (1400 mg dvakrat na dan) z lopinavirjem/ritonavirjem 533 mg/133 mg dvakrat na dan povečala incidenco neželenih učinkov na prebavila in zvišanja trigliceridov s kombinirano shemo.
English: Caution should be exercised in administering Lopinavir/Ritonavir Mylan with bosentan.
Slovenian: Pri uporabi zdravila Lopinavir/ritonavir Mylan z bosentanom je potrebna previdnost.
English: Due to CYP3A inhibition by lopinavir/ritonavir, concentrations of lurasidone are expected to increase.
Slovenian: Zaradi inhibicije CYP3A z lopinavirjem/ritonavirjem se pričakuje povečanje koncentracij lurasidona.
English: Therefore, lopinavir/ritonavir tablets may be taken with or without food.
Slovenian: Tablete lopinavirja/ritonavirja lahko torej bolnik vzame s hrano ali brez nje.
English: Due to CYP3A inhibition by lopinavir/ritonavir, concentrations of pimozide are expected to increase.
Slovenian: Zaradi inhibicije CYP3A z lopinavirjem/ritonavirjem se pričakuje povečanje koncentracij pimozida.
English: The concomitant administration with fusidic acid is contraindicated in dermatological infections (see section 4.5).
Slovenian: Sočasna uporaba fusidne kisline je kontraindicirana pri dermatoloških okužbah.
English: AUC: ↑ 49-fold Due to CYP3A inhibition by lopinavir/ritonavir.
Slovenian: AUC: ↑ 49-krat zaradi zavrtja CYP3A z lopinavirjem/ritonavirjem
English: Ergot alkaloids Dihydroergotamine, ergonovine, ergotamine, methylergonovine
Slovenian: Ergot alkaloidi dihidroergotamin, ergonovin, ergotamin in metilergonovin
English: Lopinavir/Ritonavir Mylan 100 mg/25 mg film-coated tablets are white, film coated, ovaloid, biconvex beveled edge tablets debossed with 'MLR4' on one side of the tablet and plain on the other side.
Slovenian: Zdravilo Lopinavir/ritonavir Mylan 100 mg/25 mg filmsko obložene tablete so bele, približno ovalne, bikonveksne filmsko obložene tablete, z zaobljenimi robovi in vtisnjeno oznako 'MLR4' na eni strani in brez oznake na drugi strani.
English: The coadministration of vorapaxar with Lopinavir/Ritonavir Mylan is not recommended (see section 4.4 and refer to the vorapaxar SmPC).
Slovenian: Sočasna uporaba vorapaksarja z zdravilom Lopinavir/ritonavir Mylan ni priporočljiva (glejte poglavje 4.4 in glejte povzetek glavnih značilnosti zdravila za vorapaksar).
English: Thereby, increasing the risk of serious arrhythmias from these agents (see section 4.5).
Slovenian: Zaradi tega večje tveganje resnih motenj srčnega ritma, povezanih s tema zdraviloma (glejte poglavje 4.5).
English: Lopinavir/Ritonavir Mylan 200 mg/50 mg film-coated tablets OPA/Al/PVC-aluminium blister pack.
Slovenian: Zdravilo Lopinavir/ritonavir Mylan 200 mg/50 mg filmsko obložene tablete Je pakirano v OPA/Alu/PVC-aluminjaste pretisne omote.
English: The dose of Lopinavir/Ritonavir Mylan may need adjusting.
Slovenian: Za zdravilo Lopinavir/ritonavir Mylan odmerka ni treba prilagajati .
English: The co-administration of riociguat with Lopinavir/Ritonavir Mylan is not recommended (see section 4.4 and refer to riociguat SmPC).
Slovenian: Sočasna uporaba riociguata z zdravilom Lopinavir/ritonavir Mylan ni priporočljiva (glejte poglavje 4.4 in glejte povzetek glavnih značilnosti zdravila za riociguat.
English: Lopinavir/Ritonavir Mylan 100 mg/25 mg film-coated tablets OPA/Al/PVC-aluminium blister pack.
Slovenian: Zdravilo Lopinavir/ritonavir Mylan 100 mg/25 mg filmsko obložene tablete Je pakirano v OPA/Alu/PVC-aluminjaste pretisne omote.
English: Component of a multipack, can't be sold separately.
Slovenian: Ni za posamezno prodajo.
English: Raltegravir: AUC: ↔ Cmax: ↔ C12 : ↓ 30%
Slovenian: AUC: ↔ Cmax: ↔ C12 : ↓ 30% lopinavir: ↔
English: − Haemophilia type A and B as lopinavir/ritonavir might increase the risk of bleeding.
Slovenian: - hemofilijo tipa A in B, ker lopinavir/ritonavir lahko zviša tveganje za krvavitve; - sladkorno bolezen, ker so pri bolnikih, ki so jemali lopinavir/ritonavir, poročali o zvišanih vrednostih krvnega sladkorja; - bolezni jeter.
English: Ranitidine (150 mg single dose)
Slovenian: Prilagoditev odmerka ni potrebna ranitidin (enkratni odmerek 150 mg)
English: The concomitant administration of Lopinavir/Ritonavir Mylan and ranolazine is contraindicated (see section 4.3).
Slovenian: Sočasna uporaba zdravila Lopinavir/ritonavir Mylan in ranolazina je kontraindicirana (glejte poglavje 4.3).
English: MARKETING AUTHORISATION NUMBER(S) EU/1/15/1067/008
Slovenian: ŠTEVILKA(E) DOVOLJENJA(DOVOLJENJ) ZA PROMET EU/1/15/1067/008
English: AUC: ↓ 54% Cmax: ↓ 53% Cmin: ↓ 52%
Slovenian: AUC: ↓ 54% Cmax: ↓ 53% Cmin: ↓ 52% Lopinavir: ↔
English: Cmin: ↑ 3.5-fold
Slovenian: Cmin: ↑ 3,5-krat
English: The use of avanafil with Lopinavir/Ritonavir Mylan is contraindicated (see section 4.3).
Slovenian: Uporaba avanafila z zdravilom Lopinavir/ritonavir Mylan je kontraindicirana (glejte poglavje 4.3).
English: Ombitasvir: ↔
Slovenian: valproat: ↓
English: Patients who exhibit these signs or symptoms should be evaluated and lopinavir/ritonavir therapy should be suspended if a diagnosis of pancreatitis is made (see section 4.8).
Slovenian: Če se diagnoza pankreatitisa potrdi, je treba zdravljenje z lopinavirjem/ritonavirjem prekiniti (glejte poglavje 4.8).
English: Due to CYP3A inhibition by lopinavir/ritonavir, concentrations of ranolazine are expected to increase.
Slovenian: Zaradi inhibicije CYP3A z lopinavirjem/ritonavirjem se pričakuje povečanje koncentracij ranolazina.
English: Lopinavir/Ritonavir Mylan 200 mg/50 mg film-coated tablets.
Slovenian: Lopinavir/ritonavir Mylan 200 mg/50 mg filmsko obložene tablete lopinavir/ritonavir
English: − elbasvir/grazoprevir (used to treat chronic hepatitis C virus [HCV]);
Slovenian: Lopinavir/ritonavir Mylan'' zgoraj); - zdravila za zdravljenje tuberkuloze (bedakilin, delamanid); - protivirusna zdravila za zdravljenje kronične okužbe z virusom hepatitisa C (HCV) pri odraslih
English: The combination of lopinavir/ritonavir with atorvastatin is not recommended.
Slovenian: Uporaba zdravila Lopinavir/ritonavir Mylan v kombinaciji z atorvastatinom ni priporočljiva.
English: Salmeterol:
Slovenian: (KOPB) (npr. salmeterol):
English: Ethinyl Oestradiol: ↓
Slovenian: Peroralni kontraceptivi etinilestradiol etinilestradiol: ↓
English: Severe hepatic insufficiency.
Slovenian: - Bolniki s hudo okvaro jeter.
English: Medicinal product class
Slovenian: FARMACEVTSKI PODATKI
English: NAME OF THE MEDICINAL PRODUCT Lopinavir/Ritonavir Mylan 100 mg/25 mg film-coated tablets lopinavir/ritonavir
Slovenian: Lopinavir/ritonavir Mylan 100 mg/25 mg filmsko obložene tablete lopinavir/ritonavir
English: Concentrations may be decreased due to CYP3A induction by carbamazepine and phenobarbital.
Slovenian: lopinavir: zaradi indukcije CYP3A s karbamazepinom oz. fenobarbitalom se koncentracija lahko zmanjša.
English: - Multipacks containing 120, 120x1 (4 cartons of 30 or 30x1) or 360 (12 cartons of 30) film-coated tablets.
Slovenian: Na voljo sta naslednji velikosti pakiranj: - Skupno pakiranje s 120 ali 120 x 1 (4 škatle po 30 ali 30 x 1) filmsko obloženo tableto.
English: Lopinavir/ritonavir medicinal product level decreased Herbal products
Slovenian: Zmanjšanje k oncentracije zdravila z lopinavirjem/ritonavirjem
English: Lower respiratory tract infection, skin infections including cellulitis, folliculitis and furuncle
Slovenian: Bolezni krvi in limfatičnega sistema pogosti anemija, levkopenija, nevtropenija in limfadenopatija
English: Ketoconazole, Itraconazole: Serum concentrations may be increased due to CYP3A inhibition by lopinavir/ritonavir.
Slovenian: Antimikotiki ketokonazol in itrakonazol ketokonazol, itrakonazol: zaradi zavrtja CYP3A z lopinavirjem/ritonavirjem se koncentracija v serumu lahko
English: Lopinavir and ritonavir levels may increase on stopping St John's wort.
Slovenian: Koncentraciji lopinavirja in ritonavirja se lahko po prekinitvi jemanja šentjanževke povečata.
English: Trazodone single dose (Ritonavir, 200 mg BID)
Slovenian: Antidepresivi in anksiolitiki trazodon, enkraten odmerek (ritonavir, 200 mg dvakrat na dan)
English: Cmax
Slovenian: Cmax in Cmin
English: Concomitant administration of elbasvir/grazoprevir with Lopinavir/Ritonavir Mylan is contraindicated (see section 4.3).
Slovenian: Sočasna uporaba elbasvirja/grazoprevirja in zdravila Lopinavir/ritonavir Mylan je kontraindicirana (glejte poglavje 4.3).
English: AUC: ↑ 153% Cmax: ↑ 55%
Slovenian: AUC: ↑ 32% Cmax: ↔ Cmin: ↑ 51%
English: Sorbitan laurate Silica, colloidal anhydrous Copovidone
Slovenian: Jedro tablete sorbitan lavrat silicijev dioksid, koloidni, brezvodni kopovidon natrijev stearilfumarat
English: Fosamprenavir (1400 mg BID) (Lopinavir/ritonavir 533/133 mg BID)
Slovenian: (lopinavir/ ritonavir 533 mg/133 mg dvakrat na dan)
English: Caution should be exercised in administering afatinib with Lopinavir/Ritonavir Mylan.
Slovenian: Pri uporabi afatiniba z zdravilom Lopinavir/ritonavir Mylan je potrebna previdnost.
English: Serum concentrations may be increased due to CYP3A inhibition by lopinavir/ritonavir.
Slovenian: Serumske koncentracije se lahko povečajo zaradi inhibicije CYP3A z lopinavirjem/ritonavirjem.
English: 400/100 mg BID)
Slovenian: 400 mg/100 mg dvakrat na dan)
English: Patients should be monitored closely for a decreased VPA effect when Lopinavir/Ritonavir Mylan and valproic acid or valproate are given concomitantly.
Slovenian: Pri bolnikih z okvarjenim delovanjem jeter ali ledvic je treba klaritromicin hkrati z zdravilom Lopinavir/ritonavir Mylan uporabljati previdno.
English: What Lopinavir/Ritonavir Mylan contains
Slovenian: Kaj vsebuje zdravilo Lopinavir/ritonavir Mylan
English: Lovastatin and Simvastatin Lovastatin, Simvastatin: Markedly increased plasma concentrations due to CYP3A inhibition by lopinavir/ritonavir.
Slovenian: Klinično priporočilo glede sočasne uporabe z zdravilom Lopinavir/ritonavir Mylan lovastatin in simvastatin lovastatin, simvastatin: izrazito povečanje koncentracije v plazmi zaradi zavrtja CYP3A z lopinavirjem/ritonavirjem.
English: Fusidic acid:
Slovenian: Antiinf ektivi: fusidna kislina fusidna kislina:
English: Rosuvastatin, 20 mg QD Rosuvastatin: AUC: ↑ 2-fold
Slovenian: rosuvastatin, 20 mg enkrat na dan rosuvastatin:
English: QD BID Difference [95% CI]
Slovenian: 1x nadan 2x na dan Razlika [95% IZ]
English: − muscle disorders such as weakness and spasms, pain in the joints, muscles and back;
Slovenian: - Siljenje na bruhanje, bruhanje, bolečine v trebuhu, težave pri dihanju in hudo šibkost mišic nog in rok.
English: − Nausea, vomiting, abdominal pain as large increases in the amount of triglycerides (fats in the blood) have been considered a risk factor for pancreatitis (inflammation of the pancreas) and these symptoms may suggest this condition.
Slovenian: Močno povečanje vrednosti trigliceridov (vrste maščob v krvi) velja za dejavnik tveganja za to bolezen.
English: Mean baseline CD4+ T-cell count was 259 cells/mm3 (range: 2 to 949 cells/mm3) and mean baseline plasma HIV-1 RNA was 4.9 log10 copies/ml (range: 2.6 to 6.8 log10 copies/ml).
Slovenian: povprečna izhodiščna HIV-1 RNA v plazmi pa je bila 4,9 log10 izvodov/ml (razpon: od 2,6 do 6,8 log10 izvodov/ml).
English: 30x1 Film-coated tablets
Slovenian: 30 x 1 filmsko obložena tableta Sestavni del skupnega pakiranja.
English: Immune Reconstitution Inflammatory Syndrome
Slovenian: Vnetni sindrom imunsk e rekonstitucije
English: Caution should be exercised in administering phenytoin with Lopinavir/Ritonavir Mylan.
Slovenian: Pri uporabi karbamazepina ali fenobarbitala z zdravilom Lopinavir/ritonavir Mylan je potrebna previdnost.
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each film-coated tablet contains 100 mg of lopinavir co-formulated with 25 mg ritonavir as a pharmacokinetic enhancer.
Slovenian: NAVEDBA ENE ALI VEČ ZDRAVILNIH UČINKOVIN Ena filmsko obložena tableta vsebuje 100 mg lopinavirja, v kombinaciji s 25 mg ritonavirja kot farmakokinetičnim ojačevalcem.
English: - 1 bottle of 60 film-coated tablets.
Slovenian: Na voljo je naslednja velikost pakiranja: - 1 vsebnik s 60 filmsko obloženimi tabletami.
English: AUC: ↑ 13-fold Due to CYP3A inhibition by lopinavir/ritonavir.
Slovenian: AUC: ↑ 13-krat Zaradi zavrtja CYP3A z lopinavirjem/ritonavirjem.
English: PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING BOTTLE (LABEL)
Slovenian: PODATKI NA STIČNI OVOJNINI VSEBNIK (NALEPKA)
English: Increased plasma concentrations of venetoclax.
Slovenian: Zvišana koncentracija venteloklaksa v plazmi.
English: It is not recommended to coadminister Lopinavir/Ritonavir Mylan and boceprevir.
Slovenian: Sočasna uporaba zdravila Lopinavir/ritonavir Mylan in boceprevirja ni priporočljiva.
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER CARTON OF BLISTER MULTIPACK (WITH BLUE BOX)
Slovenian: PODATKI NA ZUNANJI OVOJNINI ŠKATLA ZA SKUPNO PAKIRANJE S PRETISNIMI OMOTI (VKLJUČNO Z MODRIM OKENCEM)
English: Rash including maculopapular rash, dermatitis/rash including eczema and seborrheic dermatitis, night sweats, pruritus
Slovenian: Bolezni kože in podkožja pogosti izpuščaj vključno z makropapularnim izpuščajem, dermatitis/izpuščaj vključno z ekcemom in seboreičnim dermatitisom, nočno potenje, pruritus občasni alopecija, kapilaritis, vaskulitis neznana pogostnost
English: To date, there is limited human experience of acute overdose with lopinavir/ritonavir.
Slovenian: Izkušnje z akutnim prevelikim odmerjanjem lopinavirja/ritonavirja pri ljudeh so doslej omejene.
English: What Lopinavir/Ritonavir Mylan looks like and contents of the pack Lopinavir/Ritonavir Mylan 200 mg/50 mg film-coated tablets are white, film coated, ovaloid, biconvex beveled edge tablets debossed with 'MLR3' on one side of the tablet and plain on the other side.
Slovenian: Zdravilo Lopinavir/ritonavir Mylan 200 mg/50 mg filmsko obložene tablete so bele, približno ovalne, bikonveksne filmsko obložene tablete, z zaobljenimi robovi in vtisnjeno oznako 'MLR3' na eni strani in brez oznake na drugi strani.
English: Concentrations may be affected when co-administered with lopinavir/ritonavir due to CYP2C9 induction.
Slovenian: Antikoagulansi varfarin varfarin: indukcija CYP2C9 med sočasno uporabo z lopinavirjem/ritonavirjem lahko vpliva na koncentracijo.
English: MARKETING AUTHORISATION NUMBER(S) EU/1/15/1067/001
Slovenian: ŠTEVILKA(E) DOVOLJENJA(DOVOLJENJ) ZA PROMET EU/1/15/1067/001
English: Clinical monitoring of therapeutic and adverse effects is recommended when these medicines are concomitantly administered with Lopinavir/Ritonavir Mylan.
Slovenian: Med uporabo teh zdravil z zdravilom Lopinavir/ritonavir Mylan je priporočljiv kliničen nadzor terapevtskih in neželenih učinkov.
English: AUC: ↑ 3-fold Cmax: ↑ 1.8-fold
Slovenian: Cmax: ↑ 1,8-krat
English: Lopinavir/Ritonavir Mylan must not be administered once daily in combination with phenytoin.
Slovenian: Zdravila Lopinavir/ritonavir Mylan v kombinaciji s fenitoinom ni dovoljeno dajati enkrat na dan.
English: AUC: ↑ 11-fold Due to CYP3A inhibition by lopinavir/ritonavir.
Slovenian: AUC: ↑ 11-krat zaradi zavrtja CYP3A z lopinavirjem/ritonavirjem.
English: The combination of Lopinavir/Ritonavir Mylan with atorvastatin is not recommended.
Slovenian: Sočasna uporaba zdravila Lopinavir/ritonavir Mylan in simeprevirja ni priporočljiva.
English: MARKETING AUTHORISATION NUMBER(S) EU/1/15/1067/004
Slovenian: ŠTEVILKA(E) DOVOLJENJA(DOVOLJENJ) ZA PROMET EU/1/15/1067/004
English: Rilpivirine (Lopinavir/ritonavir capsule 400/100 mg BID)
Slovenian: rilpivirin (lopinavir/ ritonavir kapsula
English: AUC: ↑ 13-fold Parenteral Midazolam: AUC: ↑ 4-fold
Slovenian: Klinično priporočilo glede sočasne uporabe z zdravilom Lopinavir/ritonavir Mylan midazolam Peroralni midazolam: AUC: ↑ 13-krat
English: − anticancer medicines (e.g. afatinib, ceritinib, ibrutinib, venetoclax, most tyrosine kinases inhibitors such as dasatinib and nilotinib, also vincristine and vinblastine);
Slovenian: - antibiotiki (npr. rifabutin, rifampicin, klaritromicin); - zdravila proti raku (npr. afatinib, ceritinib, ibrutinib, venetoklaks, večina zaviralcev tirozin kinaz, kot sta dasatinib in nilotinib, tudi vinkristin, vinblastin); - antikoagulanti (npr. varfarin, rivaroksaban, vorapaksar); - zdravila za zdravljenje depresije (npr. trazodon, bupropion); - zdravila za zdravljenje epilepsije (npr. karbamazepin, fenitoin, fenobarbital, lamotrigin in valproat); - zdravila zdravljenje glivičnih okužb (npr. ketokonazol, itrakonazol, vorikonazol); - zdravila za zdravljenje protina (npr. kolhicin).
English: Concentrations may be increased due to CYP3A inhibition by lopinavir/ritonavir.
Slovenian: Serumakse koncentracije se lahko povečajo zaradi inhibicije CYP3A z lopinavirjem/ritonavirjem.
English: What Lopinavir/Ritonavir Mylan contains - The active substances are lopinavir and ritonavir - The other ingredients are sorbitan laurate, colloidal anhydrous silica, copovidone, sodium stearyl fumarate, hypromellose, titanium dioxide (E171), macrogol, hydroxypropylcellulose, talc, polysorbate
Slovenian: Inhibitors'') (npr. efavirenz, nevirapin); - peroralni kontraceptivi ali kontraceptivi v obližu za preprečevanje nosečnosti (glejte poglavje spodaj z naslovom “Kontraceptivi”); - zaviralci proteaz (npr. fosamprenavir, indinavir, ritonavir, sakvinavir, tipranavir); - pomirjevala (npr. injicirani midazolam); - steroide (npr. budezonid, deksametazon, flutikazonpropionat, etinilestradiol, triamcinolon).
English: Fosamprenavir/ ritonavir (700/100 mg BID) (Lopinavir/ritonavir
Slovenian: fosamprenavir/ ritonavir (700 mg/100 mg dvakrat na dan)
English: ANNEX I
Slovenian: Zabeleženi podatk i
English: Talk to your doctor or pharmacist before taking Lopinavir/Ritonavir Mylan.
Slovenian: Pred začetkom jemanja zdravila Lopinavir/ritonavir Mylan se posvetujte z zdravnikom ali farmacevtom.
English: PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING BOTTLE MULTIPACK (LABEL)
Slovenian: PODATKI NA STIČNI OVOJNINI SKUPNO PAKIRANJE Z VSEBNIKI (NALEPKA)
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each film-coated tablet contains 200 mg of lopinavir co-formulated with 50 mg ritonavir as a pharmacokinetic enhancer.
Slovenian: NAVEDBA ENE ALI VEČ ZDRAVILNIH UČINKOVIN Ena filmsko obložena tableta vsebuje 200 mg lopinavirja, v kombinaciji s 50 mg ritonavirja kot farmakokinetičnim ojačevalcem.
English: MARKETING AUTHORISATION NUMBER(S) EU/1/15/1067/007
Slovenian: ŠTEVILKA(E) DOVOLJENJA(DOVOLJENJ) ZA PROMET EU/1/15/1067/007
English: Due to CYP3A inhibition by lopinavir/ritonavir, concentrations of alfuzosin are expected to increase.
Slovenian: Zaradi zavrtja CYP3A z lopinavirjem/ritonavirjem je treba pričakovati povečanje koncentracije alfuzosina.
English: AUC: ↑ 7.2-fold Cmax: ↑ 4.7-fold Cmin: ↑ 14.4-fold
Slovenian: 4,7-krat Cmin: ↑ 14,4-krat
English: Antimycobacterials Bedaquiline (single dose)
Slovenian: Protimikobakterijska zdravila
English: It is not recommended to coadminister Lopinavir/Ritonavir Mylan and telaprevir.
Slovenian: Sočasna uporaba zdravila Lopinavir/ritonavir Mylan in telaprevirja ni priporočljiva.
English: The dose of maraviroc should be decreased to 150 mg twice daily during co-administration with Lopinavir/Ritonavir Mylan 400/100 mg twice daily.
Slovenian: Med sočasno uporabo zdravila Lopinavir/ritonavir Mylan 400 mg/100 mg dvakrat na dan je potrebno odmerek maraviroka zmanjšati na 150 mg dvakrat na dan.
English: MARKETING AUTHORISATION NUMBER(S) EU/1/15/1067/003
Slovenian: ŠTEVILKA(E) DOVOLJENJA(DOVOLJENJ) ZA PROMET EU/1/15/1067/003
English: − medicines used to treat asthma and other lung-related problems such as chronic obstructive pulmonary disease (COPD) (e.g. salmeterol);
Slovenian: takrolimus); - zdravila, ki se uporabljajo za odvajanje od kajenja (npr. bupropion); - morfinu podobna zdravila (npr. metadon); - nenukleozidni zaviralci reverzne transkriptaze (NNRTI - ''Non-nucleoside reverse transcriptase
English: Lopinavir/Ritonavir Mylan 100 mg/25 mg film-coated tablets.
Slovenian: Lopinavir/ritonavir Mylan 100 mg/25 mg filmsko obložene tablete Lopinavir/ritonavir Mylan 200 mg/50 mg filmsko obložene tablete
English: Fosamprenavir:
Slovenian: Lopinavir:
English: − night sweats, itching, rash including raised bumps on the skin, infection of the skin, inflammation of skin or hair pores, accumulation of fluid in the cells or tissues.
Slovenian: - hemoroidi; - vnetje jeter vključno z zvišanimi vrednostmi jetrnih encimov; - alergijske reakcije vključno s koprivnico in vnetjem v ustih; - okužbe spodnjih dihal; - povečanje limfnih vozlov; - impotenca, nenormalno močna ali podaljšana menstrualna krvavitev ali odsotnost menstruacije; - mišične bolezni, kot so šibkost mišic in mišični krči, bolečine v sklepih, mišicah in hrbtu; - poškodbe perifenih živcev; - nočno potenje, srbenje, izpuščaj vključno s kožnimi bulami, okužbe kože, vnetje kože ali lasnih por, zastajanje tekočine v celicah ali tkivih.
English: Dexamethasone
Slovenian: Benzodiazepini
English: Uncommon Rhabdomyolysis, osteonecrosis
Slovenian: lopinavir: ↔ Inhibitorji proteaze HCV
English: Lopinavir provides the antiviral activity of lopinavir/ritonavir.
Slovenian: Mehanizem delov anja Protivirusno delovanje lopinavirja/ritonavirja zagotavlja lopinavir.
English: Concentrations are decreased due to CYP3A induction by phenytoin.
Slovenian: lopinavir: zaradi indukcije CYP3A s fenitoinom se koncentracija zmanjša.